Guerenne, Laura
18  Ergebnisse:
Personensuche X
?
1

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initia..:

Gorombei, Petra ; Guidez, Fabien ; Ganesan, Saravanan...
International Journal of Molecular Sciences.  22 (2021)  19 - p. 10658 , 2021
 
?
4

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initia..:

Gorombei, Petra ; Guidez, Fabien ; Ganesan, Saravanan...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910658.  , 2021
 
?
6

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initia..:

Gorombei, Petra ; Guidez, Fabien ; Ganesan, Saravanan...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910658.  , 2021
 
?
7

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initia..:

Gorombei, Petra ; Guidez, Fabien ; Ganesan, Saravanan...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910658.  , 2021
 
?
8

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initia..:

Gorombei, Petra ; Guidez, Fabien ; Ganesan, Saravanan...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910658.  , 2021
 
?
10

GEP analysis validates high risk MDS and acute myeloid leuk..:

Guerenne, Laura ; Beurlet, Stéphanie ; Said, Mohamed...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13045-016-0235-8.  , 2016
 
?
11

GEP analysis validates high risk MDS and acute myeloid leuk..:

Guerenne, Laura ; Beurlet, Stéphanie ; Said, Mohamed...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13045-016-0235-8.  , 2016
 
?
13

GEP analysis validates high risk MDS and acute myeloid leuk..:

Guerenne, Laura ; Beurlet, Stéphanie ; Said, Mohamed...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13045-016-0235-8.  , 2016
 
?
14

GEP analysis validates high risk MDS and acute myeloid leuk..:

Guerenne, Laura ; Beurlet, Stéphanie ; Said, Mohamed...
Guerenne , L , Beurlet , S , Said , M , Gorombei , P , Le Pogam , C , Guidez , F , de la Grange , P , Omidvar , N , Vanneaux , V , Mills , K , Mufti , G J , Sarda-Mantel , L , Noguera , M E , Pla , M , Fenaux , P , Padua , R A , Chomienne , C & Krief , P 2016 , ' GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways ' , Journal of Hematology & Oncology , vol. 9 , 5 . https://doi.org/10.1186/s13045-016-0235-8.  , 2016
 
1-15